Evidence map›Paper›PMID 36251657›Full record

ArticlePloS one2022

Agent-based model projections for reducing HIV infection among MSM: Prevention and care pathways to end the HIV epidemic in Chicago, Illinois.

Wouter Vermeer, Can Gurkan, Arthur Hjorth, Nanette Benbow, Brian M Mustanski, David Kern, C Hendricks Brown, Uri Wilensky

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. A Review of Network Models for HIV Spread.Journal of acquired immune deficiency syndromes (1999) · 2025
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Wouter VermeerCenter for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM), Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.ORCID 0000-0002-9684-6347
Can GurkanCenter for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM), Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Arthur HjorthDepartment of Management, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-8652-0354
Nanette BenbowCenter for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM), Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.ORCID 0000-0001-6715-1530
Brian M MustanskiCenter for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM), Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
David KernChicago Department of Public Health (CDPH), Chicago, IL, United States of America.
C Hendricks BrownCenter for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM), Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Uri WilenskyNorthwestern Institute for Complex Systems (NICO), Northwestern University, Evanston, IL, United States of America.
Northwestern University · USAarhus University · DKChicago Department of Public Health · US

Funding

The RADAR cohort study of multilevel Influences on HIV and substance useU01DA036939 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Brian Mustanski, Michael E Newcomb · 2014 to 2026
$29.5M
INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
NIDA NIH HHS P30 DA027828NIDA NIH HHS U01 DA036939
6 · The paper itself

Abstract

Our objective is to improve local decision-making for strategies to end the HIV epidemic using the newly developed Levers of HIV agent-based model (ABM). Agent-based models use computer simulations that incorporate heterogeneity in individual behaviors and interactions, allow emergence of systemic behaviors, and extrapolate into the future. The Levers of HIV model (LHM) uses Chicago neighborhood demographics, data on sex-risk behaviors and sexual networks, and data on the prevention and care cascades, to model local dynamics. It models the impact of changes in local preexposure prophylaxis (PrEP) and antiretroviral treatment (ART) (ie, levers) for meeting Illinois' goal of "Getting to Zero" (GTZ) -reducing by 90% new HIV infections among men who have sex with men (MSM) by 2030. We simulate a 15-year period (2016-2030) for 2304 distinct scenarios based on 6 levers related to HIV treatment and prevention: (1) linkage to PrEP for those testing negative, (2) linkage to ART for those living with HIV, (3) adherence to PrEP, (4) viral suppression by means of ART, (5) PrEP retention, and (6) ART retention. Using tree-based methods, we identify the best scenarios at achieving a 90% HIV infection reduction by 2030. The optimal scenario consisted of the highest levels of ART retention and PrEP adherence, next to highest levels of PrEP retention, and moderate levels of PrEP linkage, achieved 90% reduction by 2030 in 58% of simulations. We used Bayesian posterior predictive distributions based on our simulated results to determine the likelihood of attaining 90% HIV infection reduction using the most recent Chicago Department of Public Health surveillance data and found that projections of the current rate of decline (2016-2019) would not achieve the 90% (p = 0.0006) reduction target for 2030. Our results suggest that increases are needed at all steps of the PrEP cascade, combined with increases in retention in HIV care, to approach 90% reduction in new HIV diagnoses by 2030. These findings show how simulation modeling with local data can guide policy makers to identify and invest in efficient care models to achieve long-term local goals of ending the HIV epidemic.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesAnti-Retroviral AgentsBayes TheoremChicagoCritical PathwaysHomosexuality, MaleHumansIllinoisMaleAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID36251657
PMCPMC9576079
OpenAlexW4306630482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.